← Back to Clinical Trials
Recruiting NCT05477680

NCT05477680 Intraoperative Brain Shift Calculation Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05477680
Status Recruiting
Phase
Sponsor Sklifosovsky Institute of Emergency Care
Condition Tumor, Brain
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2022-09-01
Primary Completion 2027-08-31

Trial Parameters

Condition Tumor, Brain
Sponsor Sklifosovsky Institute of Emergency Care
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 100 Years
Start Date 2022-09-01
Completion 2027-08-31
Interventions
Navigation-guided surgery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of the study is to calculate magnitude, type of intraoperative brain shift and assess possibility of it's prediction.

Eligibility Criteria

Inclusion Criteria: * all intracranial tumors * cavernomas * arteriovenous malformations * spontaneous (non-traumatic) intracerebral hemorrhages * traumatic intracerebral hemorrhages * supratentorial localization * newly diagnosed * age 18-100 years * stable hemodynamics * error of patient registration in neuronavigation no more than 2 mm Exclusion Criteria: * rapid cerebral dislocation

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology